本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准 确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带 的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声 明：保证季度报告中财务信息的真实、准确、完整。 3.第三季度报告是否经过审计 □ 是 √ 否 杭州中亚机械股份有限公司 2021 年第三季度报告 证券代码：300512 证券简称：中亚股份 公告编号：2021-145 杭州中亚机械股份有限公司 2021 年第三季度报告 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 本报告期比上年同期增 | 年初至报告期末 | 年初至报告期末比上年 | | --- | --- | --- | --- | --- | | | | 减 | | 同期增减 | | 营业收入（元） | 302,039,098.83 | 93.39% | 794,767,376.03 | 56.11 ...

Revenue and Profitability - The company's operating revenue for the reporting period was ¥492,728,277.20, representing a 39.62% increase compared to ¥352,916,403.53 in the same period last year[30]. - The net profit attributable to shareholders was ¥87,807,929.87, a significant increase of 163.00% from ¥33,387,590.35 in the previous year[30]. - The net profit after deducting non-recurring gains and losses was ¥81,085,881.69, reflecting a 222.90% increase from ¥25,111,642.44 year-on-year[30]. - The basic earnings per share rose to ¥0.32, up 166.67% from ¥0.12 in the same period last year[30]. - The company's total comprehensive income for the first half of 2021 was ¥87.58 million, compared to ¥33.46 million in the same period of 2020[184]. - The company reported a total profit of ¥103.68 million for the first half of 2021, a 61.5% increase from ¥39.71 million in the same period of 2020[183]. Customer Concentration and Market Expansion - The company's revenue from the top five customers accounted for 59.70% of total operating income in the first half of 2021, compared to 57.24% in 2020[10]. - The company is actively expanding its customer base in industries such as healthcare, beverages, edible oils, daily chemicals, and food to mitigate customer concentration risk[10]. - The company plans to expand its market presence in the healthcare, beverage, edible oil, daily chemical, and food industries to mitigate customer concentration risks[85]. Research and Development - The company emphasizes continuous innovation and increased R&D investment to maintain a technological edge and stabilize gross profit margins[11]. - The company's R&D investment increased by 44.32% to ¥22,588,216.27, up from ¥15,651,069.50 in the previous year, reflecting a focus on innovation and product development[53]. - The company is planning to increase its investment in research and development to innovate new products and technologies[89]. Production Capacity and Investment - The company has invested in new intelligent packaging machinery and new bottled aseptic filling equipment to increase production capacity[12]. - The company has invested a total of RMB 41,445.56 million from the raised funds, which is approximately 62.3% of the total raised amount[71]. - The company reported an investment income of CNY 2,590,117.69, accounting for 2.50% of total profit, primarily from financial products[56]. Financial Position and Cash Flow - The total assets at the end of the reporting period were ¥2,195,115,244.42, a 7.14% increase from ¥2,048,908,928.71 at the end of the previous year[30]. - The company reported a net cash flow from operating activities of -¥74,596,969.45, a decline of 140.73% compared to -¥30,987,450.10 in the previous year[30]. - The company's cash and cash equivalents increased by ¥24,874,206.26, contrasting with a decrease of ¥215,026,566.69 in the previous year, indicating improved cash flow management[53]. Risk Factors - The company is facing risks related to the tight supply of key raw materials, which could extend delivery times[13]. - The company acknowledges the challenges posed by the overall economic situation affecting downstream industry sales growth[7]. - The company is experiencing fluctuations in raw material prices, which are impacting procurement costs and overall profit margins[89]. Environmental and Compliance - The company has established a comprehensive quality, environment, and occupational health management system to ensure compliance with environmental standards[103]. - There were no administrative penalties related to environmental issues during the reporting period[103]. - The company is committed to maintaining its environmental management practices and has established a KPI assessment mechanism[103]. Shareholder and Stock Information - The company proposed a cash dividend of 0.55 yuan per 10 shares (including tax), totaling 15,012,431.50 yuan, which represents 100% of the distributable profit[94][95][96]. - The total number of shares for the cash dividend calculation is 272,953,300 shares after deducting shares held in the repurchase account[95]. - The company completed the first grant registration of the 2021 restricted stock incentive plan, with 354,000 shares granted after some participants voluntarily waived their rights[100]. Strategic Initiatives - The company aims to enhance management and attract talent in technology, management, production, and marketing to support its expanding operational scale[9]. - The company is gradually expanding into the unmanned retail sector, developing and producing unmanned retail equipment[37]. - The company emphasizes the importance of enhancing management and human resources to meet the demands of its expanding operations[86].

Financial Performance - The company's operating revenue for Q1 2021 was ¥192,233,958.70, representing a 13.20% increase compared to ¥169,821,126.59 in the same period last year[8]. - Net profit attributable to shareholders was ¥28,155,944.84, a significant increase of 106.49% from ¥13,635,695.94 year-on-year[8]. - The net profit after deducting non-recurring gains and losses reached ¥26,774,870.93, up 145.62% from ¥10,900,799.95 in the previous year[8]. - The basic earnings per share increased to ¥0.1043, reflecting a growth of 106.53% compared to ¥0.0505 in the same period last year[8]. - Total revenue for the main business reached ¥191,628,583.85, representing a year-on-year increase of 12.89%[21]. - Net profit for the first quarter was ¥28,196,162.43, a 112.63% increase compared to the same period last year[19]. - Operating profit increased by 105.10% to ¥33,547,208.19, attributed to changes in product sales structure and a significant rise in gross margin[18]. - The total comprehensive income for Q1 2021 was CNY 28,196,162.43, compared to CNY 13,260,568.37 in the same period last year[57]. Assets and Liabilities - Total assets at the end of the reporting period were ¥2,099,784,753.52, an increase of 2.48% from ¥2,048,908,928.71 at the end of the previous year[8]. - The net assets attributable to shareholders rose to ¥1,472,063,505.31, marking a 3.50% increase from ¥1,422,219,751.51 at the end of the last year[8]. - Total liabilities were reported at CNY 622,547,057.06, slightly up from CNY 621,555,203.64 in the previous period[47]. - The company's equity attributable to shareholders reached CNY 1,472,063,505.31, compared to CNY 1,422,219,751.51 at the end of 2020, reflecting an increase of about 3.5%[48]. - Total current assets as of March 31, 2021, were ¥1,506,991,692.40, compared to ¥1,461,791,098.17 at the end of 2020, indicating a growth in current assets[45]. Cash Flow - The company reported a net cash flow from operating activities of -¥55,878,375.19, a slight improvement of 4.10% compared to -¥58,269,922.66 in the previous year[8]. - The company's cash inflow from operating activities was ¥197,233,058.06, a 48.42% increase year-on-year[19]. - The cash flow from operating activities was CNY 193,922,587.32, up from CNY 127,112,725.51 in the previous period[63]. - The ending balance of cash and cash equivalents stood at CNY 190.72 million, up from CNY 103.14 million year-on-year[65]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 12,618[11]. - The largest shareholder, Hangzhou Peiyuan Investment Co., Ltd., held 38.03% of the shares, totaling 104,040,044 shares[11]. Operational Insights - The company reported a 62.56% increase in sales expenses, totaling ¥12,404,591.53, driven by business growth[18]. - Research and development expenses increased by 58.08% to ¥12,888,649.19, reflecting higher investment in R&D activities[18]. - Accounts receivable rose by 39.56% to ¥230,409,539.07, mainly due to an increase in sales at the end of the reporting period[18]. - The company’s top five suppliers accounted for 18.91% of total procurement, indicating no significant reliance on any single supplier[21]. - The top five customers contributed a total sales revenue of 147.86 million yuan, accounting for 77.16% of the main business revenue in Q1 2021, indicating a significant customer concentration risk[25]. Strategic Initiatives - The company plans to actively expand into industries such as healthcare, beverages, edible oils, daily chemicals, and food to mitigate customer concentration risks[25]. - The company has initiated a stock incentive plan, granting 3.54 million shares at a price of 5.83 yuan per share to 86 incentive objects, aimed at enhancing employee motivation[29]. - The company is investing in new intelligent packaging machinery and new sterile filling equipment projects to increase production capacity, which may lead to risks if market expansion does not keep pace[27]. - The company has established a wholly-owned subsidiary in Ma'anshan with a registered capital of 10 million yuan to enhance its operational capabilities[31]. Risks and Challenges - The company is facing risks related to the tight supply of key raw materials, such as PLC servo control systems, which could extend delivery times[28]. - The company is monitoring raw material price fluctuations that may impact procurement costs[40]. - The company is implementing new leasing standards starting from 2021, affecting the financial statements[69].

Financial Performance - The net profit attributable to the parent company decreased by 59.32% year-on-year in 2020[4]. - The company's operating revenue for 2020 was ¥662,050,554.46, a decrease of 22.85% compared to ¥858,139,604.75 in 2019[26]. - The net profit attributable to shareholders for 2020 was ¥44,196,833.66, down 59.32% from ¥108,656,286.76 in the previous year[26]. - The net profit after deducting non-recurring gains and losses was ¥28,896,767.38, a decline of 68.56% from ¥91,915,810.61 in 2019[26]. - The basic earnings per share for 2020 was ¥0.16, a decrease of 60.00% compared to ¥0.40 in 2019[26]. - The total operating revenue for 2020 was ¥662,050,554.46, a decrease of 22.85% compared to ¥858,139,604.75 in 2019[63]. - Revenue from the dairy industry dropped by 41.52% to ¥428,558,167.32, while revenue from the beverage industry increased by 366.39% to ¥85,369,967.23[63]. - The company's smart packaging equipment accounted for 68.63% of total revenue, totaling ¥454,337,763.37, down 26.50% from the previous year[63]. Profit Distribution - The company plans to distribute a cash dividend of 0.4 yuan per 10 shares to shareholders[14]. - The cash dividend for 2020 represents 24.76% of the net profit attributable to ordinary shareholders, compared to 19.88% for 2019 and 18.83% for 2018[127]. - The company’s total distributable profit was reported at 443,285,020.27 CNY[122]. - The company’s cash dividend represented 100% of the total profit distribution amount[122]. - The cash dividend distribution was executed in compliance with the company’s articles of association and shareholder resolutions[122]. - The company maintained a stable profitability and good financial condition in 2020, aligning the dividend distribution plan with its actual operating situation and future development strategy[125]. - The cash dividend conditions include having an unqualified audit report and ensuring sufficient cash flow to meet operational and investment plans[130]. - The company has consistently adhered to its profit distribution policy, ensuring a minimum cash dividend ratio of 20% during its growth phase[124]. Customer Concentration and Market Expansion - The top five customers accounted for 57.24% of the main business revenue in 2020, compared to 54.27% in 2019 and 63.78% in 2018[10]. - The company acknowledges risks related to customer concentration and is working to diversify its client base[11]. - The company aims to expand its customer base in industries such as healthcare, beverages, edible oils, daily chemicals, and food[8]. - The company is actively developing its sterile equipment technology and exploring new expansion plans[118]. - The company plans to expand into sectors such as healthcare, edible oils, daily chemicals, beverages, and solid food industries, leveraging its core technologies[109]. Research and Development - The company is increasing R&D investment to maintain its technological advantage and control production costs[12]. - Research and development expenses amounted to ¥39,432,283.29, representing 5.96% of total revenue, up from 5.70% in 2019[76]. - In 2020, the company obtained 35 new patents, including 6 invention patents, and applied for 33 new invention patents[57]. - The company aims to enhance its R&D and innovation capabilities, focusing on high-end products that are sterile, energy-efficient, and integrated, to increase market share domestically and internationally[108]. Operational Efficiency and Management - The company is focused on improving management and attracting talent to meet the demands of its expanding operations[9]. - The company utilizes an ERP system for unified management of production and procurement processes, enhancing operational efficiency[37]. - The company is committed to providing comprehensive solutions, including lifecycle maintenance and planning for intelligent packaging production lines[36]. - The company aims to enhance its competitiveness by increasing product research and market expansion efforts[60]. - The company is committed to achieving significant improvements in manufacturing efficiency and product quality by 2025, as outlined in the "Made in China 2025" initiative[109]. Technological Advancements - The company has achieved significant technological advancements, with its equipment nearing international standards and successfully replacing imports in the domestic market[42]. - The company has established itself as a leading smart packaging machinery manufacturer in China, with strong R&D capabilities and unique core technologies, particularly in sterile technology[41]. - The company emphasizes strong testing capabilities for new product development, ensuring seamless integration with production processes and reducing debugging time and costs[47]. Financial Position and Investments - The total assets at the end of 2020 were ¥2,048,908,928.71, an increase of 6.90% from ¥1,916,715,188.53 at the end of 2019[26]. - The net assets attributable to shareholders increased by 1.74% to ¥1,422,219,751.51 at the end of 2020 from ¥1,397,834,527.09 in 2019[26]. - The company reported a net increase in cash and cash equivalents of ¥16,601,585.20, a decrease of 79.57% from the previous year[79]. - The company has committed CNY 38.9 million in entrusted financial management, with CNY 25.4 million in bank financial products and CNY 12.5 million in securities firm products[171]. Risks and Challenges - The company faces risks from fluctuations in downstream industries, particularly in the fast-moving consumer goods sector, which could impact its operating performance[114]. - The company is at risk of extended delivery times due to potential supply tightness of key raw materials, such as PLC servo control systems[115]. - The company's gross profit margins have declined from 44.60% in 2018 to 28.54% in 2020, highlighting the risk of further margin erosion[114]. Subsidiaries and Acquisitions - The company established a new subsidiary, Nanjing Grey Intelligent Equipment Co., Ltd., without significant impact on overall operations[106]. - The company acquired a 55% stake in Nanjing Grey Intelligent Equipment Co., Ltd. for CNY 5.5 million on June 11, 2020, expanding its consolidation scope[141]. - The company transferred 70% equity of its subsidiary, Hangzhou Maijiesi Refrigeration Technology Co., Ltd., for RMB 3.5 million, resulting in no longer holding any equity in the subsidiary[180]. Lease Agreements - The company has a lease agreement with Mengniu Dairy for a factory rental agreement with a total annual rent of CNY 60,000 starting from July 1, 2018[156]. - The company signed multiple lease agreements for properties, with annual rents ranging from CNY 1.5 million to CNY 93 million, covering areas from 1,077.6 square meters to 5,022 square meters[164][165][166].

Financial Performance - Net profit attributable to shareholders was ¥10,786,630, a decrease of 76.88% year-on-year[6] - Operating revenue for the reporting period was ¥156,179,627.26, down 36.27% from the same period last year[6] - Basic earnings per share decreased by 77.78% to ¥0.04 compared to ¥0.18 in the same period last year[6] - Operating profit decreased by 55.12% to ¥52,472,387.87 compared to the same period last year, primarily due to a decline in gross margin[14] - Net profit fell by 56.68% to ¥43,154,430.64, attributed to a decrease in gross margin[14] - Total profit decreased by 55.55% to ¥52,234,522.12, reflecting the same gross margin issues[14] - Net profit for Q3 2020 was CNY 10,500,294.06, significantly lower than CNY 46,146,075.06 in the same period last year[37] - The total profit for Q3 2020 was CNY 13,719,277.09, significantly lower than CNY 57,363,532.90 in Q3 2019, representing a decrease of 76.06%[44] Cash Flow - The net cash flow from operating activities was ¥84,093,238, a significant improvement from a negative cash flow of ¥26,880,506 in the previous year[6] - Cash flow from operating activities increased significantly to ¥53,105,788.52, compared to a negative cash flow of -¥115,284,817.79 in the previous year[15] - Cash received from tax refunds rose by 111.86% to ¥7,331,069.25, indicating improved cash inflow from tax-related activities[14] - Cash received from other operating activities surged by 319.59% to ¥79,951,255.08, mainly due to loans from the controlling shareholder[14] - The cash flow from operating activities generated a net amount of ¥53,105,788.52, compared to a net outflow of ¥115,284,817.79 in the same quarter last year[53] - The net cash flow from operating activities for the current period is ¥57,163,766.05, compared to a negative cash flow of ¥61,380,257.36 in the previous period, indicating a significant improvement[55] Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,982,403,403.70, an increase of 3.46% compared to the previous year[6] - The total liabilities of the company were CNY 553,837,507.32, up from CNY 513,549,385.11, marking an increase of approximately 7.8%[28][29] - The company's current assets totaled CNY 1,410,746,415.66, compared to CNY 1,338,371,650.23 at the end of 2019, reflecting a growth of approximately 5.5%[26][29] - The company's inventory decreased from CNY 630,627,525.01 at the end of 2019 to CNY 428,692,787.11, representing a reduction of approximately 32%[26][29] - The total assets of the company are reported at ¥1,916,108,188.53, with total equity amounting to ¥1,402,558,803.42[62] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 12,443[9] - The largest shareholder, Hangzhou Peiyuan Investment Co., Ltd., holds 38.53% of the shares[9] - The company established Nanjing Grey Intelligent Equipment Co., Ltd., resulting in a 31.33% increase in minority interests to ¥7,001,369.60[13] Government Support - The company received government subsidies amounting to ¥7,992,569.41 during the reporting period[7] - Deferred income increased by 76.47% to ¥13,299,939.68, due to an increase in government subsidies awaiting recognition[13] Market and Future Outlook - The company is focusing on expanding its market presence in the beverage and pharmaceutical sectors, as indicated by ongoing research and development efforts[21] - Future outlook includes enhancing production capacity and exploring potential mergers and acquisitions to strengthen market position[21] Research and Development - Research and development expenses for Q3 2020 were CNY 25,673,941.41, a decrease of 15.66% from CNY 30,204,394.60 in the same period last year[44] - The company has implemented new revenue and leasing standards starting from 2020, which may affect the financial statements[58] - The company has implemented the new revenue recognition standards starting January 1, 2020, affecting the reporting of contract assets and liabilities[64]

Financial Performance - The company's operating revenue for the current reporting period is ¥352,916,403.53, representing a decrease of 5.44% compared to the same period last year [24]. - The net profit attributable to shareholders of the listed company is ¥33,387,590.35, down 38.87% year-on-year [24]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is ¥25,111,642.44, a decline of 48.85% compared to the previous year [24]. - The basic earnings per share is ¥0.12, which is a decrease of 40.00% from ¥0.20 in the same period last year [24]. - The company's total assets at the end of the reporting period amount to ¥1,897,687,437.50, reflecting a decrease of 0.96% from the end of the previous year [24]. - The net assets attributable to shareholders of the listed company increased to ¥1,410,736,343.58, showing a growth of 0.97% compared to the previous year [24]. - The company reported a net cash flow from operating activities of -¥30,987,450.10, indicating a negative cash flow situation [24]. - The company's revenue for the first half of 2020 was approximately ¥352.92 million, a decrease of 5.44% compared to ¥373.22 million in the same period last year [57]. - The net profit for the first half of 2020 was CNY 32.65 million, down 39% from CNY 53.46 million in the first half of 2019 [171]. - The total comprehensive income for the first half of 2020 was CNY 47,141,911.24, reflecting a decrease of 20.3% from CNY 59,189,979.97 in the same period of 2019 [176]. Customer Concentration Risk - The top five customers accounted for 63.78%, 54.27%, and 72.73% of the main business revenue in 2018, 2019, and the first half of 2020, highlighting a high customer concentration risk [7]. - The company aims to expand its customer base in the healthcare, beverage, edible oil, daily chemical, and food industries to mitigate risks associated with customer concentration [7]. - The sales revenue from the top five customers accounted for 63.78%, 54.27%, and 72.73% of the main business income in 2018, 2019, and the first half of 2020, highlighting a high customer concentration risk [84]. Investment and Capital Expenditure - The company plans to invest in new intelligent packaging machinery and new sterile filling equipment, which will increase production capacity and fixed asset depreciation [9]. - The investment amount during the reporting period was RMB 8,006,811.82, representing an increase of 85.56% compared to the same period last year [67]. - The new intelligent packaging machinery project has an investment of RMB 36,210 million, with 53.78% of the investment completed by the end of the reporting period [74]. - The new bottled aseptic filling equipment project has an investment of RMB 16,466 million, with 61.36% of the investment completed by the end of the reporting period [74]. - The research and development center and laboratory construction project has an investment of RMB 5,810 million, with 52.72% of the investment completed by the end of the reporting period [74]. Research and Development - The company plans to increase R&D investment to maintain its technological leadership and control production costs to stabilize gross margins [8]. - The company has made significant progress in technology research and development, obtaining 14 new patents in the first half of 2020, including 6 invention patents [53]. - The company has invested in advanced R&D hardware and has been recognized as a key research and development center in China [42]. - The company’s R&D team possesses both solid theoretical knowledge and practical experience, maintaining industry-leading research capabilities [42]. Operational Challenges - The company is facing challenges due to a slowdown in sales growth in the downstream liquid food industry, which directly impacts its operational performance [4]. - The company is focused on maintaining close communication with clients and developing products that meet their needs to address challenges posed by industry fluctuations [84]. - The company is undergoing a digital transformation, aiming to enhance its core competencies by integrating service, technology, and digital capabilities [52]. Cash Flow and Financial Position - The company's cash balance decreased by 68.66%, from ¥313,165,561.06 at the end of 2019 to ¥98,138,994.37 at the end of June 2020 [39]. - The cash flow from operating activities showed a significant improvement, with a net cash outflow of approximately -¥30.99 million, compared to -¥88.40 million in the previous year [57]. - The total amount of funds raised by the company was RMB 70,571.25 million, with a net amount of RMB 66,486 million after deducting underwriting and advisory fees [71]. - The company reported a total cash inflow from investment activities of CNY 817,923,452.23, compared to CNY 1,063,091,993.17 in the first half of 2019 [178]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 16,791 [141]. - The largest shareholder, Hangzhou Peiyuan Investment Co., Ltd., holds 104,040,044 shares, representing a significant portion of the company's equity [143]. - The company reported a total of 64,772,028 shares held by directors and senior management at the end of the reporting period, with an increase of 196,400 shares by the general manager, Shi Zheng [153]. - The company did not engage in any repurchase transactions during the reporting period, reflecting a stable capital management strategy [143]. Leasing and Related Party Transactions - The company signed a lease agreement with Peiyuan Investment for an office space of 60 square meters at an annual rent of RMB 36,000, effective from January 1, 2020, to December 31, 2022 [108]. - The company has engaged in related party transactions amounting to 170.78 thousand yuan for purchasing sterilization modules and 79.29 thousand yuan for equipment sales during the reporting period [104]. Market Expansion - The company is actively expanding into the international dairy market, leveraging the "Belt and Road" initiative to explore opportunities in neighboring countries [35]. - The company is gradually expanding into the unmanned retail sector, developing and producing unmanned retail equipment [31]. - The company aims to become a global leader in the intelligent packaging machinery industry, focusing on technological advancement and market expansion [55].

Financial Performance - Total revenue for Q1 2020 was ¥169,821,126.59, a decrease of 18.85% compared to ¥209,258,978.73 in the same period last year[6] - Net profit attributable to shareholders was ¥13,635,695.94, down 54.58% from ¥30,022,903.53 year-on-year[6] - Net profit excluding non-recurring gains and losses was ¥10,900,799.95, a decline of 57.27% compared to ¥25,509,246.72 in the previous year[6] - Basic earnings per share decreased by 54.59% to ¥0.0505 from ¥0.1112 in the same period last year[6] - The company's main business revenue decreased by 18.81% to ¥16,975.06 million in Q1 2020[16] - The company's main business gross margin for Q1 2020 was 27.09%, a decrease from 37.06% in 2019[20] - Total operating revenue for Q1 2020 was CNY 169,821,126.59, a decrease from CNY 209,258,978.73 in the previous period[44] - Net profit for the first quarter was CNY 13,260,568.37, down from CNY 29,397,899.52 year-over-year, representing a decline of approximately 54.9%[46] - Operating profit decreased to CNY 16,356,528.59 from CNY 34,265,438.23, reflecting a decline of about 52.3%[46] - The total comprehensive income for the first quarter was CNY 13,260,568.37, down from CNY 29,397,899.52, indicating a decline of approximately 54.9%[47] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,876,366,157.51, a decrease of 2.11% from ¥1,916,715,188.53 at the end of the previous year[6] - Current assets totaled CNY 1,186,708,382.04, down from CNY 1,234,978,437.69 at the end of 2019[40] - Total assets amounted to CNY 1,847,826,932.01, compared to CNY 1,876,797,730.45 in the previous period[41] - Total liabilities decreased to CNY 449,916,929.15 from CNY 504,214,682.40[42] - The company's equity increased to CNY 1,397,910,002.86 from CNY 1,372,583,048.05[42] - Accounts payable decreased to CNY 132,984,705.64 from CNY 148,893,574.60[41] - The company reported a decrease in employee compensation payable to CNY 14,036,482.40 from CNY 26,248,403.96[41] - The company’s retained earnings rose to CNY 436,415,285.26 from CNY 411,598,641.37[42] - The total equity attributable to shareholders was CNY 1,397,834,527.09[61] Cash Flow - The company reported a net cash flow from operating activities of -¥58,269,922.66, compared to -¥54,538,479.32 in the same period last year[6] - Cash flow from operating activities was CNY 132,886,370.68, compared to CNY 176,123,497.02 in the previous period, indicating a decrease of approximately 24.6%[52] - The net cash flow from operating activities was -44,010,003.36 RMB, a significant decrease compared to the previous period's positive cash flow of 16,307,169.79 RMB[57] - The net cash flow from investing activities was -154,551,090.50 RMB, compared to -371,936.39 RMB in the previous period, indicating increased cash outflows for investments[58] - Cash inflows from operating activities totaled 118,278,779.08 RMB, while cash outflows were 162,288,782.44 RMB, resulting in a net cash outflow from operations[57] - The company reported a decrease in cash and cash equivalents of 197,924,331.45 RMB during the period, contrasting with an increase of 14,286,928.80 RMB in the previous period[58] Investments and Subsidiaries - The company plans to invest 20 million RMB in its wholly-owned subsidiary, increasing its registered capital from 80.5 million RMB to 81 million RMB[23] - The company has established a wholly-owned subsidiary in Hong Kong with an investment of 10 million HKD[21] - The company has completed the registration of its Hong Kong subsidiary and the capital increase for its subsidiary, indicating progress in its expansion strategy[21][23] - Total raised funds amounted to RMB 66,486 million, with RMB 1,963.21 million invested in the current quarter[29] - Cumulative investment in raised funds reached RMB 40,099.54 million, with a 0.00% change in purpose for the funds[29] - The company temporarily used RMB 6,500 million of idle raised funds to supplement working capital, which was fully returned by February 13, 2020[30] Operational Challenges and Strategies - The company has faced challenges due to the slowdown in sales growth in the downstream liquid food industry[20] - The company is actively expanding into the healthcare, edible oil, daily chemical, and food industries to diversify its customer base[20] - The company has committed to increasing R&D investment to maintain its technological advantage and stabilize gross margins[20] - The company is focused on enhancing management and human resources to meet the demands of its expanding operational scale[20] Other Financial Metrics - Trade receivables increased by 178.79% to ¥2,300,000.00 due to an increase in notes receivable[15] - Other income increased by 229.44% to ¥3,471,964.58, mainly due to increased government subsidies[14] - Sales expenses decreased by 45.78% to ¥7,630,804.99, impacted by the pandemic[14] - Financial expenses turned positive with an income of ¥3,332,998.11 due to increased interest income[14] - The company’s tax expenses decreased by 49.97% to ¥2,757,427.01, reflecting a reduction in total profit[14] - Research and development expenses were CNY 8,153,449.45, compared to CNY 9,585,896.34 in the previous period, indicating a reduction of approximately 14.9%[49] - Total operating costs were CNY 153,093,501.02, down from CNY 178,456,659.38, showing a decrease of about 14.2%[49]

Financial Performance - The company's operating revenue for 2019 was ¥858,139,604.75, representing a 19.49% increase compared to ¥718,186,789.63 in 2018[19]. - The net profit attributable to shareholders for 2019 was ¥108,656,286.76, a decrease of 41.71% from ¥186,406,886.08 in 2018[19]. - The net profit after deducting non-recurring gains and losses was ¥91,915,810.61, down 39.01% from ¥150,697,295.32 in 2018[19]. - Basic earnings per share for 2019 were ¥0.40, a decline of 42.03% from ¥0.69 in 2018[19]. - The company's cash flow from operating activities was negative at -¥61,701,118.73, compared to -¥23,242,085.09 in 2018[19]. - Total assets at the end of 2019 were ¥1,916,715,188.53, a decrease of 4.02% from ¥1,996,958,032.82 at the end of 2018[19]. - The net assets attributable to shareholders increased by 5.67% to ¥1,397,834,527.09 at the end of 2019 from ¥1,322,774,177.80 at the end of 2018[19]. - The company's accounts receivable at the end of 2019 amounted to ¥201,957,209.27, representing a 31.96% increase from ¥153,044,406.03 at the end of 2018[37]. - The company's prepayments decreased by 56.01%, with a balance of ¥10,063,956.47 at the end of 2019 compared to ¥22,875,718.60 at the end of 2018[37]. - The company's cash and cash equivalents increased by ¥81,280,391.42, contrasting with a decrease of ¥33,384,739.77 in the previous year[76]. Customer and Market Diversification - In 2019, the combined sales revenue from the top five customers accounted for 54.27% of the main business income, down from 63.78% in 2018 and 69.60% in 2017, reflecting efforts to diversify the customer base[6]. - The company is actively expanding into the healthcare, edible oil, daily chemical, and food industries to reduce customer concentration risks and enhance revenue streams[4]. - The company will focus on consolidating its leading position in the dairy industry while expanding its customer base in other sectors to improve operational performance[8]. - The company has a strong market growth potential, particularly in the dairy sector, where per capita consumption is still low compared to developed countries[33]. - The company is actively expanding into international markets, particularly in countries along the "Belt and Road" initiative, leveraging its competitive pricing and technology[33]. Research and Development - The company is committed to increasing R&D investment to maintain technological leadership and timely launch new products to stabilize gross profit margins[7]. - The company’s R&D expenses increased by 43.73% to ¥48,941,250.15, representing 5.70% of total revenue[70][72]. - The company has a robust R&D capability, being a key contributor to national and industry standards, particularly in sterile technology[35]. - The company has developed advanced technologies in high cleanliness and high precision filling, sterile environment control, and dry sterilization, enhancing equipment performance and production efficiency[40]. - The company has established a comprehensive testing platform for sterile filling equipment, significantly reducing debugging time and costs[41]. - The company has developed intelligent post-packaging equipment to meet the growing demand for automation in production due to rising labor costs[34]. - The company plans to enhance R&D efforts and introduce new products to meet customer demands, aiming to increase revenue from sectors such as beverages and pharmaceuticals[126]. Operational Efficiency and Cost Management - The overall economic situation has led to a slowdown in sales growth in the downstream liquid food industry, posing challenges to the company's operations[4]. - The company aims to enhance management and recruit talent in technology, management, production, and marketing to meet the demands of its expanding operational scale[5]. - The company plans to reduce operational costs by 30% and production cycles by 30% by 2020, as part of the "Made in China 2025" initiative[98]. - The company is focused on enhancing operational efficiency, targeting a reduction in production costs by 15% through process optimization initiatives[117]. - The company will implement a digital transformation strategy in 2020, introducing various digital management systems to enhance operational efficiency and service capabilities[103]. Dividend Policy and Shareholder Relations - The company plans to distribute a cash dividend of 0.8 RMB per 10 shares (including tax) based on a total of 270 million shares, with no bonus shares issued[8]. - The cash dividend accounted for 100% of the total distributable profit of 411,598,641.37 yuan[109]. - The cash dividend distribution for 2019 represents 19.88% of the net profit attributable to ordinary shareholders, which was 108,656,286.76 yuan[113]. - The company announced a cash dividend of 0.80 yuan per 10 shares (including tax), totaling 21,600,000 yuan for the fiscal year 2019[111]. - The company has ensured that minority shareholders had the opportunity to express their opinions and that their legal rights were protected[109]. - The company will actively communicate with shareholders, especially minority shareholders, during the decision-making process for profit distribution[120]. Strategic Initiatives and Future Outlook - The company plans to enhance its international business and accelerate overseas market expansion to create greater value for shareholders[54]. - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 25% based on anticipated market expansion and new product launches[117]. - A strategic acquisition of a local competitor is in progress, expected to enhance the company's production capacity by 30%[118]. - The company is actively seeking investment opportunities that complement its technology and market expansion efforts, focusing on both horizontal and vertical integration[102]. - The company plans to stabilize its stock price if it falls below the latest audited net asset value per share, with specific measures to be implemented within 10 trading days[122]. Compliance and Governance - Compliance with regulatory requirements remains a priority, with ongoing efforts to ensure transparency and accountability in financial reporting[118]. - The company has committed to ensuring that executive compensation is linked to the execution of return measures[127]. - The company will not engage in transactions that harm the rights of shareholders and will strictly adhere to relevant laws and regulations regarding related party transactions[121]. - The company has established a legal responsibility for the accuracy and completeness of its prospectus[124]. - The company will take legal and effective measures to prevent its controlled entities from competing with the issuer's expanded business[121].

Financial Performance - Operating revenue for the reporting period was CNY 245,070,028.55, an increase of 21.89% year-on-year [6]. - Net profit attributable to shareholders was CNY 46,650,272.16, a decrease of 7.14% compared to the same period last year [6]. - Basic earnings per share for the reporting period were CNY 0.1728, down 7.15% year-on-year [6]. - The company’s operating profit decreased by 30.39% to 116,917,023.93, attributed to a rise in operating costs outpacing revenue growth [14]. - Net profit for the first nine months of 2019 was 99,607,983.28, a decrease of 32.85% year-over-year [15]. - Total operating revenue for Q3 2019 was CNY 245,070,028.55, an increase of 21.9% compared to CNY 201,059,409.79 in the same period last year [34]. - Net profit for Q3 2019 was CNY 46,146,075.06, a decrease of 7.4% from CNY 50,017,406.45 in Q3 2018 [36]. - Basic earnings per share for Q3 2019 were CNY 0.1728, down from CNY 0.1861 in Q3 2018 [36]. - The total comprehensive income for the period was CNY 108,617,638.21, compared to CNY 150,320,252.52 in the previous period, indicating a decrease of approximately 27.8% [47]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,921,504,520.38, a decrease of 3.78% compared to the end of the previous year [6]. - The company’s total assets amounted to CNY 1,880,424,159.43, slightly up from CNY 1,879,881,690.48 year-over-year [32]. - Total liabilities decreased to CNY 518,686,918.57 from CNY 593,124,969.79 year-over-year, a reduction of 12.6% [32]. - Total liabilities decreased by 30.37% to 282,025,453.90, mainly due to a reduction in customer prepayments [14]. - Total liabilities reached CNY 666,288,236.50, with current liabilities at CNY 655,213,538.29 [60]. - Total equity increased to CNY 1,396,512,128.91 from CNY 1,330,669,796.32, showing a growth of about 4.9% [27]. - The company’s total liabilities and equity combined also equaled CNY 1,879,881,690.48 [66]. Cash Flow - The net cash flow from operating activities for the year-to-date was CNY -115,284,817.79 [6]. - Cash inflow from operating activities amounted to CNY 510,149,485.21, slightly increasing from CNY 506,358,604.61 in the previous period [49]. - Cash inflow from investment activities was CNY 1,463,689,768.62, down from CNY 2,315,359,554.65 in the previous period, representing a decline of approximately 36.8% [51]. - The ending balance of cash and cash equivalents was CNY 190,305,493.98, down from CNY 522,573,447.61 in the previous period, reflecting a decrease of about 63.7% [51]. - The company’s cash flow from operating activities showed a net outflow, indicating potential liquidity challenges moving forward [50]. Shareholder Information - The company had 18,875 common shareholders at the end of the reporting period [10]. - The largest shareholder, Hangzhou Peiyuan Investment Co., Ltd., held 38.53% of the shares [10]. - The company did not engage in any repurchase transactions during the reporting period [11]. Research and Development - Research and development expenses increased by 58.86% to 30,204,394.60 due to higher personnel costs and direct investments [14]. - Research and development expenses increased to CNY 10,646,354.14, up 70.0% from CNY 6,247,375.87 in the previous year [34]. - The company plans to continue focusing on R&D and market expansion to drive future growth [34]. Investment and Financial Management - Non-recurring gains and losses totaled CNY 7,185,302.62, primarily from government subsidies and investment income [7]. - The company reported a significant decrease in investment income, down to 1,724,593.33, primarily due to reduced financial product purchases [14]. - The total assets under management for the newly established investment partnership is 1.003 billion, with the company contributing 1 billion [17]. - The company has a long-term investment strategy with CNY 477,070,002.73 in long-term equity investments [64].

Revenue and Profitability - Total revenue for the reporting period reached ¥373,221,347.61, an increase of 18.54% compared to ¥314,856,028.05 in the same period last year[24]. - Net profit attributable to shareholders decreased by 44.66% to ¥54,617,165.48 from ¥98,693,528.83 year-on-year[24]. - Net profit after deducting non-recurring gains and losses was ¥49,095,886.73, down 33.84% from ¥74,213,013.08 in the previous year[25]. - Basic and diluted earnings per share decreased by 45.95% to ¥0.20 from ¥0.37 year-on-year[25]. - The company achieved operating revenue of RMB 373.22 million in the first half of 2019, representing an 18.54% increase year-on-year[61]. - The net profit attributable to the parent company was RMB 54.62 million, a decrease of 44.66% compared to the same period last year[61]. - The total comprehensive income for the first half of 2019 was CNY 59,189,979.97, compared to CNY 94,660,120.52 in the same period of 2018[179]. Financial Position - Total assets at the end of the reporting period were ¥1,948,545,982.37, a decrease of 2.42% from ¥1,996,958,032.82 at the end of the previous year[25]. - The company's total assets amounted to approximately RMB 1,948.55 million, a decrease from RMB 1,996.96 million at the end of 2018[162]. - The company's current assets totaled RMB 1,389.18 million, down from RMB 1,441.89 million at the end of 2018, indicating a decline of about 3.7%[163]. - The company's total equity as of June 30, 2019, was CNY 1,311,795,968.65, an increase from CNY 1,286,756,720.69 at the end of 2018[170]. - The total liabilities at the end of the reporting period were 6,890 million yuan, reflecting a manageable debt level[190]. Cash Flow and Liquidity - The net cash flow from operating activities was negative at ¥88,404,311.22, compared to a negative ¥9,962,248.26 in the same period last year[25]. - The company's cash and cash equivalents decreased by RMB 141.71 million, influenced by comprehensive activities in operations, investments, and financing[65]. - The cash flow from tax refunds was 774,675.09 CNY, a notable increase from 25,484.37 CNY in the first half of 2018, indicating improved tax recovery efforts[185]. - The cash and cash equivalents at the end of the reporting period stood at 32,357,088.45 CNY, a decrease from 404,084,039.47 CNY at the end of the first half of 2018, representing a decline of about 92%[186]. Investment and R&D - The company plans to invest in new intelligent packaging machinery and new bottled aseptic filling equipment, which will increase production capacity[8]. - Research and development investment increased by 53.20% to RMB 19.56 million, focusing on high cleanliness, high capacity, and low carbon technologies[65]. - The company has a strong research and development capability, recognized as a "China Dairy Packaging Machinery Research and Development Center" and a "Zhejiang Province High-tech Research and Development Center" among others[46]. - The company has accumulated a wealth of proprietary technologies in high-precision filling and packaging processes, significantly improving equipment performance and production efficiency[1]. Market and Customer Base - The company's main business revenue from the top five customers accounted for 56.64% in the first half of 2019, down from 63.78% in 2018[6]. - The company aims to expand its customer base in the healthcare, edible oil, daily chemical, and food industries to mitigate customer concentration risks[6]. - The company is actively pursuing market expansion in countries along the "Belt and Road" initiative, leveraging its competitive pricing and technology[38]. - The company is expanding into other industries beyond dairy, including food, beverage, and healthcare, driven by rising demand for high-end packaging equipment[38]. Operational Challenges - The overall economic situation has led to a slowdown in sales growth in the downstream liquid food industry, posing challenges to the company's operations[3]. - The company faces risks related to the inability to adapt management levels and human resources to the expanding operational scale[4]. - The company is facing risks from fluctuations in downstream industries, particularly in the liquid food sector, which may impact operational performance[89]. Corporate Governance and Shareholder Matters - The company will not distribute cash dividends or issue bonus shares for the reporting period[9]. - The company held its annual general meeting with a 69.32% investor participation rate on May 16, 2019[96]. - The company has fulfilled its commitments regarding shareholding restrictions and voluntary lock-up periods as stipulated during its IPO[98]. - The largest shareholder, Hangzhou Peiyuan Investment Co., Ltd., holds 38.53% of the shares, totaling 104,040,044 shares[147]. Strategic Initiatives - The company plans to enhance management and actively recruit talent in technology, management, production, and marketing to meet the demands of its expanding operations[90]. - The company is exploring potential mergers and acquisitions to enhance its competitive advantage in the market[190]. - The company plans to use a total of at least RMB 3 million for stock repurchase if the stock price stabilization plan is triggered, with a maximum of RMB 10 million for multiple triggers within a single fiscal year[103].